{"DataElement":{"publicId":"3371444","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the thyroid tumor based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"3180233v1.0:3371420v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3180233","version":"1","preferredName":"Thyroid Gland Neoplasm Pathologic N Stage","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control._A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"3366311v1.0:2428379v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3366311","version":"1","preferredName":"Thyroid Gland Neoplasm","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12400:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland","conceptCode":"C12400","definition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B784C9DE-7AB2-3473-E040-BB89AD43638B","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"ONEDATA","dateModified":"2012-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5DB3-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3371420","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 N Stage","preferredDefinition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3371420v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N1b","valueDescription":"Thyroid Cancer pN1b TNM Finding v7","ValueMeaning":{"publicId":"3180247","version":"1","preferredName":"Thyroid Cancer pN1b TNM Finding v7","longName":"3180247","preferredDefinition":"Thyroid cancer with metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pN1b TNM Finding v7","conceptCode":"C89155","definition":"Thyroid cancer with metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F8C2ED-3527-F051-E040-BB89AD434511","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-AB84-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"N1a","valueDescription":"Thyroid Cancer pN1a TNM Finding","ValueMeaning":{"publicId":"3180249","version":"1","preferredName":"Thyroid Cancer pN1a TNM Finding","longName":"3180249","preferredDefinition":"Thyroid cancer with metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pN1a TNM Finding v6 and v7","conceptCode":"C60874","definition":"Thyroid cancer with metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F8C2ED-354D-F051-E040-BB89AD434511","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-AB99-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"N1","valueDescription":"Thyroid Cancer pN1 TNM Finding","ValueMeaning":{"publicId":"3180251","version":"1","preferredName":"Thyroid Cancer pN1 TNM Finding","longName":"3180251","preferredDefinition":"Thyroid cancer with metastasis to regional lymph nodes. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pN1 TNM Finding v6 and v7","conceptCode":"C60873","definition":"Thyroid cancer with metastasis to regional lymph nodes. (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F8C2ED-3573-F051-E040-BB89AD434511","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-ABAE-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"N0","valueDescription":"Thyroid Cancer pN0 TNM Finding","ValueMeaning":{"publicId":"3180253","version":"1","preferredName":"Thyroid Cancer pN0 TNM Finding","longName":"3180253","preferredDefinition":"Thyroid cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pN0 TNM Finding v6 and v7","conceptCode":"C60871","definition":"Thyroid cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F8C2ED-3599-F051-E040-BB89AD434511","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-ABC3-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"NX","valueDescription":"Thyroid Cancer pNX TNM Finding","ValueMeaning":{"publicId":"3180255","version":"1","preferredName":"Thyroid Cancer pNX TNM Finding","longName":"3180255","preferredDefinition":"Thyroid cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pNX TNM Finding v6 and v7","conceptCode":"C60872","definition":"Thyroid cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F8C2ED-35BF-F051-E040-BB89AD434511","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-ABD8-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3371419","version":"1","preferredName":"Thyroid Cancer TNM Finding v7 American Joint Committee on Cancer N Stage Stage","preferredDefinition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89145:C39315:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer TNM Finding v7","conceptCode":"C89145","definition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AB51-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AB62-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"COOPERM","dateModified":"2013-10-01","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3434443","version":"1","longName":"Thyroid","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000283","version":"1","longName":"Thyroid","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"B86101DE-B344-EB91-E040-BB89AD436932","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}